Goldenwell Biotech, Inc.
GWLL · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $19,287 | $19,333 | $19,800 | $19,800 |
| - Cash | $46 | $77 | $17 | $49 |
| + Debt | $0 | $274 | $96 | $96 |
| Enterprise Value | $19,241 | $19,531 | $19,878 | $19,846 |
| Revenue | $0 | $38 | $0 | -$0 |
| % Growth | -100% | – | 100% | – |
| Gross Profit | $25 | $38 | $0 | -$0 |
| % Margin | – | 100% | – | 53.8% |
| EBITDA | -$6 | -$3 | -$32 | -$19 |
| % Margin | – | -8.3% | – | 12,111.4% |
| Net Income | -$8 | -$5 | -$34 | -$28 |
| % Margin | – | -13.9% | – | 17,427.8% |
| EPS Diluted | -0 | -0 | -0 | -0 |
| % Growth | 0% | 66.7% | 0% | – |
| Operating Cash Flow | -$31 | $59 | -$32 | -$19 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$31 | $59 | -$32 | -$19 |